DNA synthesis is not required for the commitment of murine erythroleukemia cells.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Kernen.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The response of differentiating MEL cells to the nucleotide analogue cordycepin reveals a previously unrecognized aspect of the molecular events which cause commitment of these cells to terminal erythroid differentiation. Cordycepin rapidly inhibits commitment of DMSO-treated MEL cells in a dose range which does not cause cytotoxicity. Reversal of cordycepin treatment in the presence of inducer leads to a rapid and synchronous commitment of a significant proportion of cells in the culture. These results suggest that MEL cells can be blocked just prior to the point of commitment by cordycepin treatment.
Explore the source record for details and available documents.